Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 AUD | -33.33% | -33.33% | -42.86% |
May. 16 | Avecho Biotechnology Doses First Patient in Phase III Anti-Insomnia Drug Trial | MT |
Mar. 25 | Avecho Biotechnology Begins Patient Recruitment for Phase Three Anti-Insomnia Drug Trial | MT |
- Stock Market
- Equities
- AVE Stock
- News Avecho Biotechnology Limited